AVITA Medical (AVHHL) Gross Margin (2018 - 2026)
AVITA Medical's (AVHHL) quarterly Gross Margin came in at 81.87% in Q2 2026, up 70.0% on a YoY basis from 48.16% in Q2 2025, and up 426.3% quarter-over-quarter from 15.56% in Q4 2025.
Powered by 
Analysis
AVITA Medical (AVHHL) Gross Margin (2018 - 2026) Analysis & Trends
AVITA Medical (AVHHL) has reported Gross Margin for 9 consecutive years, with 81.87% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Gross Margin rose 70.0% year-over-year to 81.87%; the trailing twelve-month figure through Jun 2026 stood at 40.82% (down 4346.0% YoY), and the FY2025 full-year result was 82.13%, down 371.0% from the prior year.
- Gross Margin rose to 81.87% in Q2 2026 per AVHHL's latest filing, from 15.56% in the prior quarter.
- Across five years, Gross Margin topped out at 87.61% in Q4 2024 and bottomed at 15.56% in Q4 2025.
- Historically, Gross Margin has averaged 79.44% across 5 years, with a median of 83.94% in 2023.
- The sharpest annual moves came in 2023 and 2025: Gross Margin jumped 778 bps in 2023, then tumbled 7206 bps in 2025.
- Over 5 years, Gross Margin stood at 85.75% in 2022, then grew by 2 bps to 87.35% in 2023, then climbed by 0 bps to 87.61% in 2024, then sank by 82 bps to 15.56% in 2025, then jumped by 426 bps to 81.87% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 81.87%, 15.56%, and 81.32% for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.62 Bn | 179.02 Bn | 7.27 Bn | 57.71% |
| 2 | Intuitive Surgical | 124.22 Bn | 119.01 Bn | 1.96 Bn | 67.78% |
| 3 | Medtronic | 118.38 Bn | 109.56 Bn | 6.34 Bn | 64.99% |
| 4 | Stryker | 104.98 Bn | 101.51 Bn | 4.50 Bn | 68.27% |
| 5 | Boston Scientific | 66.67 Bn | 66.13 Bn | 3.85 Bn | 70.71% |
| 6 | Edwards Lifesciences | 49.77 Bn | 45.52 Bn | 1.35 Bn | 77.46% |
| 7 | Alcon | 34.01 Bn | 32.56 Bn | 1.68 Bn | 60.21% |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn | 63.44% |
| 9 | Steris | 21.17 Bn | 20.69 Bn | 684.20 Mn | 45.84% |
| 10 | AVITA Medical | 61.85 Mn | 50.72 Mn | 17.77 Mn | 81.87% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 81.87% |
| Dec 31, 2025 | 15.56% |
| Sep 30, 2025 | 81.32% |
| Jun 30, 2025 | 81.17% |
| Mar 31, 2025 | 84.70% |
| Dec 31, 2024 | 87.61% |
| Sep 30, 2024 | 83.68% |
| Jun 30, 2024 | 86.11% |
| Mar 31, 2024 | 86.37% |
| Dec 31, 2023 | 87.35% |
| Sep 30, 2023 | 84.51% |
| Jun 30, 2023 | 81.25% |
| Mar 31, 2023 | 84.20% |
| Dec 31, 2022 | 85.75% |
| Sep 30, 2022 | 83.17% |
| Mar 31, 2022 | 76.42% |
| Sep 30, 2021 | 79.73% |
| Jun 30, 2021 | 77.98% |
| Mar 31, 2021 | 75.52% |
| Dec 31, 2020 | 83.91% |